Literature DB >> 14722693

Cystoscopic and DMSA findings in relation to types of reflux demonstrated on percutaneous direct radionuclide cystography in children.

Mark Roger1, A Graham Wilkinson.   

Abstract

BACKGROUND: The new technique of percutaneous direct radionuclide cystography (PDRC) allows the accurate demonstration of vesicorenal reflux under physiological conditions during resting and micturition phases. Five types of reflux have been described, the clinical relevance of which is uncertain.
OBJECTIVE: To determine whether a relationship exists between the type of reflux identified on PDRC and the appearance of the ureteric orifice at cystoscopy or the prevalence of renal abnormalities.
MATERIALS AND METHODS: The reports of 281 PDRC examinations were reviewed and 76 children with reflux formed the population of this study. Studies of these children were reviewed to classify the reflux as types 1-5, and patient records were searched for cystoscopy and DMSA scan reports.
RESULTS: Regardless of the type of reflux, the ureteric orifices were found to be open at cystoscopy in 60-66% of refluxing units. DMSA scan abnormalities were present in 68% of units with reflux at rest, 61% of units with reflux on micturition and 86% of units with reflux on both resting and micturition phases. In comparison with contralateral units that did not reflux, the presence of reflux had a significant association with openness of the ureteric orifice ( p<0.00001) and DMSA abnormality ( p<0.005).
CONCLUSIONS: Reflux of any type is strongly associated with an open ureteric orifice. Units that reflux during both resting and micturition phases had a higher incidence of DMSA abnormality than those refluxing during one phase only, but this was not statistically significant.

Entities:  

Mesh:

Year:  2004        PMID: 14722693     DOI: 10.1007/s00247-003-1070-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  19 in total

Review 1.  Diagnosis of vesico-ureteric reflux.

Authors:  M Hellström; B Jacobsson
Journal:  Acta Paediatr Suppl       Date:  1999-11

2.  Vesico-ureteric reflux and renal scarring.

Authors:  J Smellie; D Edwards; N Hunter; I C Normand; N Prescod
Journal:  Kidney Int Suppl       Date:  1975-08       Impact factor: 10.545

3.  Commentary: the management of grades I and II (nondilating) vesicoureteral reflux.

Authors:  R R Bailey
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

4.  Endoscopic treatment of vesico-ureteric reflux in children by subureteric Teflon injection: the Edinburgh experience.

Authors:  S G Mattar; J D Orr; G A MacKinlay
Journal:  J R Coll Surg Edinb       Date:  1994-02

Review 5.  Radionuclide cystography.

Authors:  J J Conway
Journal:  Contrib Nephrol       Date:  1984       Impact factor: 1.580

6.  Direct comparison of radiology and nuclear medicine cystograms in young infants with vesico-ureteric reflux.

Authors:  C J McLaren; E T Simpson
Journal:  BJU Int       Date:  2001-01       Impact factor: 5.588

7.  "Stasis"--a test for vesico-ureteric orifice competence in children with reflux.

Authors:  J E Pollet; P F Sharp; F W Smith
Journal:  Pediatr Radiol       Date:  1980-07

8.  Radionuclide cystography: the significance of retention time of the refluxed radioisotope.

Authors:  I Nissenkorn; I Gil; C Servadio; E Lubin
Journal:  J Urol       Date:  1981-10       Impact factor: 7.450

9.  Commentary: management of children with severe vesicoureteral reflux.

Authors:  J M Smellie
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

10.  The detection and characterization of vesicoureteral reflux in the child.

Authors:  R L Lebowitz
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

View more
  1 in total

1.  Types of Parenchymal Changes Diagnosed on DMSA Scans of Kidneys Affected by Different Grades of Vesicoureteral Reflux.

Authors:  Adela Arapović; Ante Punda; Dubravka Brdar; Vesna Čapkun; Diana Bajo; Daniela Veljačić; Hrvoje Punda; Ana Simičić-Majce; Mirna Saraga-Babić; Katarina Vukojević; Marijan Saraga
Journal:  Med Sci Monit       Date:  2021-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.